Phoenixville, PA based PleoPharma is readying a phase 3 study of its therapy to treat cannabis withdrawal
Co-Founder & CEO Ginger Constantine describes how some people are affected by cannabis withdrawal and discusses the dual action medicine PleaPharma is developing for it.
Comentários